BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION

Balance Sheet Details

The following tables provide details of selected balance sheet items (in millions):



	As of
Inventory	September 30, 2018		December 31, 2017
Raw materials	$	139.5	$	80.9
Work-in-process	38.5		19.7
Finished goods	192.1		140.6
Total inventory	$	370.1	$	241.2



	As of
Other accrued liabilities—short-term	September 30, 2018		December 31, 2017
Taxes payable	$	22.8	$	63.1
Litigation related accruals	54.6		13.8
Other accrued liabilities	102.4		92.0
Total other accrued liabilities—short-term	$	179.8	$	168.9



	As of
Other long-term liabilities	September 30, 2018		December 31, 2017
Income taxes—long-term	$	263.1	$	286.8
Deferred revenue—long-term	26.1		24.8
Other long-term liabilities	37.6		22.0
Total other long-term liabilities	$	326.8	$	333.6

Goodwill and Intangible Assets

The increases in goodwill and intangible assets from December 31, 2017, to September 30, 2018, primarily relate to two transactions accounted for as business combinations.

During the second quarter of fiscal 2018, the Company terminated its India distribution relationship with Vattikuti Technologies Pvt. Ltd. and acquired certain assets related to that distribution business on May 25, 2018, which collectively met the definition of a business. The transaction enhances the Company’s ability to serve patients, surgeons, and hospitals in India. The purchase consideration consisted of $38.1 million in cash. The Company preliminarily recorded $4.1 million of net tangible assets, $24.2 million of intangible assets, and $9.8 million of residual goodwill. Intangible assets included reacquired distribution rights, customer relationships, and a non-compete agreement, which are being amortized over a weighted average period of 4.3 years.

During the third quarter of fiscal 2018, the Company acquired intellectual property, exclusive field of use rights, and certain key employees from InTouch Technologies, Inc. on August 17, 2018, which collectively met the definition of a business. The transaction enhances the Company’s network capabilities in using real-time data to support surgeons. The total purchase consideration of $38.7 million, as of the acquisition date, consisted of an initial cash payment of $22.0 million and future cash payments totaling approximately $16.7 million. The Company recorded $13.3 million of intangible assets and $25.4 million of residual goodwill. Intangible assets included developed technology and a non-compete agreement, which are being amortized over a weighted average period of 5.7 years. The goodwill will be amortized for income tax purposes.

The Company has included the results of both businesses since their acquisition date in its Financial Statements, which have not been material to date. Pro forma results of operations related to the acquisitions have not been presented since the operating results of the acquired businesses are not material to the Company’s Financial Statements.

Supplemental Cash Flow Information

The following table provides supplemental non-cash investing and financing activities (in millions):



	Nine Months Ended September 30,
	2018		2017
Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment	$	84.4	$	45.1
Deferred payments related to business combinations	$	16.7	$	—